Drugs / DR-5001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00382408 | Sep 2006 → Dec 2007 | respiratory tract infectious disorder | Duramed Research | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DR-5001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00382408 ↗ |
| Route | Oral | “Both vaccine tablets were administered orally” NCT00382408 ↗ |